Multifunctional Acidocin 4356 Combats Pseudomonas aeruginosa through Membrane Perturbation and Virulence Attenuation: Experimental Results Confirm Molecular Dynamics Simulation
暂无分享,去创建一个
H. Vali | S. Arab | K. A. Noghabi | H. Zahiri | Sima Modiri | M. Soudi | R. Kasra Kermanshahi | A. Khammari | B. Cousineau
[1] M. T. B. Geller,et al. Molecular , 2019, Modern Pathology.
[2] I. Banat,et al. Natural quorum sensing inhibitors effectively downregulate gene expression of Pseudomonas aeruginosa virulence factors , 2019, Applied Microbiology and Biotechnology.
[3] S. Gharavi,et al. The role of probiotic Lactobacillus acidophilus ATCC 4356 bacteriocin on effect of HBsu on planktonic cells and biofilm formation of Bacillus subtilis. , 2018, International journal of biological macromolecules.
[4] J. Davies,et al. Suppression of Staphylococcus aureus virulence by a small-molecule compound , 2018, Proceedings of the National Academy of Sciences.
[5] R. Wubbolts,et al. Inhibition and Eradication of Pseudomonas aeruginosa Biofilms by Host Defence Peptides , 2018, Scientific Reports.
[6] A. Eldar,et al. Selection for increased quorum-sensing cooperation in Pseudomonas aeruginosa through the shut-down of a drug resistance pump , 2018, The ISME Journal.
[7] Suzana M. Ribeiro,et al. In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design , 2018, Nature Communications.
[8] Colleen E. Keohane,et al. Promysalin Elicits Species-Selective Inhibition of Pseudomonas aeruginosa by Targeting Succinate Dehydrogenase. , 2018, Journal of the American Chemical Society.
[9] R. Kümmerli,et al. Low spatial structure and selection against secreted virulence factors attenuates pathogenicity in Pseudomonas aeruginosa , 2018, The ISME Journal.
[10] M. Mangoni,et al. In vivo therapeutic efficacy of frog skin-derived peptides against Pseudomonas aeruginosa-induced pulmonary infection , 2017, Scientific Reports.
[11] L. Hodgson,et al. The Role of Rho-GTPases and actin polymerization during Macrophage Tunneling Nanotube Biogenesis , 2017, Scientific Reports.
[12] M. Seleem,et al. A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii , 2017, Scientific Reports.
[13] B. Jha,et al. Anti-quorum Sensing and Anti-biofilm Activity of Delftia tsuruhatensis Extract by Attenuating the Quorum Sensing-Controlled Virulence Factor Production in Pseudomonas aeruginosa , 2017, Front. Cell. Infect. Microbiol..
[14] William E Bentley,et al. Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models , 2017, Nature Communications.
[15] Michael Otto,et al. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance , 2017, Nature Reviews Drug Discovery.
[16] Bo Yu,et al. CDD/SPARCLE: functional classification of proteins via subfamily domain architectures , 2016, Nucleic Acids Res..
[17] T. Böttcher,et al. Synthetic quinolone signal analogues inhibiting the virulence factor elastase of Pseudomonas aeruginosa. , 2016, Chemical communications.
[18] R. Fu,et al. Simulations of Membrane-Disrupting Peptides II: AMP Piscidin 1 Favors Surface Defects over Pores. , 2016, Biophysical journal.
[19] G. Qiao,et al. Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers , 2016, Nature Microbiology.
[20] Olwyn Byron,et al. Discovery, characterization and in vivo activity of pyocin SD2, a protein antibiotic from Pseudomonas aeruginosa , 2016, The Biochemical journal.
[21] Y. Kaznessis,et al. Interactions of a class IIb bacteriocin with a model lipid bilayer, investigated through molecular dynamics simulations. , 2016, Biochimica et biophysica acta.
[22] R. Kolter,et al. Goodbye to brute force in antibiotic discovery? , 2016, Nature Microbiology.
[23] M. Balouiri,et al. Methods for in vitro evaluating antimicrobial activity: A review☆ , 2015, Journal of pharmaceutical analysis.
[24] José A. Dianes,et al. 2016 update of the PRIDE database and its related tools , 2015, Nucleic Acids Res..
[25] K. Nazmi,et al. Antimicrobial Peptide LL-37 Is Both a Substrate of Cathepsins S and K and a Selective Inhibitor of Cathepsin L. , 2015, Biochemistry.
[26] H. Vali,et al. Lipid production and mixotrophic growth features of cyanobacterial strains isolated from various aquatic sites. , 2015, Microbiology.
[27] B. Bassler,et al. Development of potent inhibitors of pyocyanin production in Pseudomonas aeruginosa. , 2015, Journal of medicinal chemistry.
[28] D. Andreu,et al. Monitoring antibacterial permeabilization in real time using time-resolved flow cytometry. , 2015, Biochimica et biophysica acta.
[29] N. Rosato,et al. Molecular dynamics methods to predict peptide locations in membranes: LAH4 as a stringent test case. , 2015, Biochimica et biophysica acta.
[30] S. Dosler,et al. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides , 2014, Peptides.
[31] J. Reymond,et al. Combining topology and sequence design for the discovery of potent antimicrobial peptide dendrimers against multidrug-resistant Pseudomonas aeruginosa. , 2014, Angewandte Chemie.
[32] M. Schaller,et al. Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide , 2014, Mucosal Immunology.
[33] Gert Vriend,et al. YASARA View—molecular graphics for all devices—from smartphones to workstations , 2014, Bioinform..
[34] D. Diep,et al. Defining the Structure and Receptor Binding Domain of the Leaderless Bacteriocin LsbB* , 2014, The Journal of Biological Chemistry.
[35] Knut Drescher,et al. A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation , 2013, Proceedings of the National Academy of Sciences.
[36] E. Sparr,et al. Ionization Constants pKa of Cardiolipin , 2013, PloS one.
[37] D. Tieleman,et al. Perspective on the Martini model. , 2013, Chemical Society reviews.
[38] J. Fox. Antimicrobial peptides stage a comeback , 2013, Nature Biotechnology.
[39] Peter M. Kasson,et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit , 2013, Bioinform..
[40] M. Nishizawa,et al. Molecular dynamics simulation analysis of membrane defects and pore propensity of hemifusion diaphragms. , 2013, Biophysical journal.
[41] R. Larson,et al. Coarse-grained molecular dynamics simulation of tethered lipid assemblies , 2013 .
[42] Kieron M. G. O'Connell,et al. Inhibition of the production of the Pseudomonas aeruginosa virulence factor pyocyanin in wild-type cells by quorum sensing autoinducer-mimics. , 2012, Organic & biomolecular chemistry.
[43] Patrick Y. Muller,et al. The determination and interpretation of the therapeutic index in drug development , 2012, Nature Reviews Drug Discovery.
[44] K. Nazmi,et al. Identification of Peptides Derived from the Human Antimicrobial Peptide LL-37 Active against Biofilms Formed by Pseudomonas aeruginosa Using a Library of Truncated Fragments , 2012, Antimicrobial Agents and Chemotherapy.
[45] Yang Zhang,et al. Ab initio protein structure assembly using continuous structure fragments and optimized knowledge‐based force field , 2012, Proteins.
[46] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[47] G. Schneider,et al. Designing antimicrobial peptides: form follows function , 2011, Nature Reviews Drug Discovery.
[48] L. Rohan,et al. Degradation of naturally occurring and engineered antimicrobial peptides by proteases. , 2011, Advances in bioscience and biotechnology.
[49] L. Garcia,et al. Quorum quenching quandary: resistance to antivirulence compounds , 2011, The ISME Journal.
[50] H. Vogel,et al. The expanding scope of antimicrobial peptide structures and their modes of action. , 2011, Trends in biotechnology.
[51] R. Brasseur,et al. The Pseudomonas aeruginosa membranes: a target for a new amphiphilic aminoglycoside derivative? , 2011, Biochimica et biophysica acta.
[52] K. Hahm,et al. Membrane perturbation by the antimicrobial peptide PMAP-23: a fluorescence and molecular dynamics study. , 2009, Biochimica et biophysica acta.
[53] Durba Sengupta,et al. Toroidal pores formed by antimicrobial peptides show significant disorder. , 2008, Biochimica et biophysica acta.
[54] R. Hancock,et al. Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation , 2008, Infection and Immunity.
[55] L. Rice. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. , 2008, The Journal of infectious diseases.
[56] O. Cholewa,et al. Limitations in the Use of Fluorescein Diacetate/Propidium Iodide (FDA/PI) and Cell Permeable Nucleic Acid Stains for Viability Measurements of Isolated Islets of Langerhans. , 2008, Current trends in biotechnology and pharmacy.
[57] K. Mathee,et al. Inhibition of Quorum Sensing-Controlled Virulence Factor Production in Pseudomonas aeruginosa by South Florida Plant Extracts , 2007, Antimicrobial Agents and Chemotherapy.
[58] H. Abriouel,et al. Diversity of enterococcal bacteriocins and their grouping in a new classification scheme. , 2007, FEMS microbiology reviews.
[59] H. Ohtake,et al. Inhibition of Quorum Sensing in Pseudomonas aeruginosa by N-Acyl Cyclopentylamides , 2007, Applied and Environmental Microbiology.
[60] R. Hancock,et al. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.
[61] A. Sali,et al. Statistical potential for assessment and prediction of protein structures , 2006, Protein science : a publication of the Protein Society.
[62] Robert E W Hancock,et al. Rational Design of α-Helical Antimicrobial Peptides with Enhanced Activities and Specificity/Therapeutic Index* , 2005, Journal of Biological Chemistry.
[63] D. Hassett,et al. The role of pyocyanin in Pseudomonas aeruginosa infection. , 2004, Trends in molecular medicine.
[64] L. Sabath,et al. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[65] Li Yang,et al. An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteria , 2003, Nature Biotechnology.
[66] S. Kjelleberg,et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors , 2003, The EMBO journal.
[67] D. Davies,et al. Understanding biofilm resistance to antibacterial agents , 2003, Nature Reviews Drug Discovery.
[68] Sejong Oh,et al. Bacteriocin Produced by Lactobacillus acidophilus ATCC 4356 , 2002 .
[69] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[70] A. Mark,et al. Simulation of the spontaneous aggregation of phospholipids into bilayers. , 2001, Journal of the American Chemical Society.
[71] K. Lewis,et al. Riddle of Biofilm Resistance , 2001, Antimicrobial Agents and Chemotherapy.
[72] R. Hancock,et al. Antibacterial Action of Structurally Diverse Cationic Peptides on Gram-Positive Bacteria , 2000, Antimicrobial Agents and Chemotherapy.
[73] P. Kollman,et al. Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models , 1992 .
[74] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[75] Zohreh Alaei. Molecular Dynamics Simulations of Axonal Membrane in Traumatic Brain Injury , 2017 .
[76] M. Dallal,et al. Antimicrobial and Anti-Swarming Effects of Bacteriocins and Biosurfactants from Probiotic Bacterial Strains against Proteus spp. , 2016 .
[77] John M. Walker,et al. The Proteomics Protocols Handbook , 2005, Humana Press.
[78] R D Appel,et al. Protein identification and analysis tools in the ExPASy server. , 1999, Methods in molecular biology.